Free Republic 2nd Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $41,560
51%  
Woo hoo!! And we're now over 51%!! Thank you all very much!! God bless.

Keyword: allergan

Brevity: Headers | « Text »
  • The White House Is Pushing Puberty Blockers for ‘Trans Kids.’ It’s Relying on a Problematic Study.

    04/05/2022 1:06:57 PM PDT · by yesthatjallen · 63 replies
    Washington Free Beacon ^ | 04 05 2022 | Chuck Ross
    The Biden administration promoted the use of puberty blockers for transgender children by citing a study from an LGBT group funded in part by a manufacturer of the controversial drugs used in gender reassignment. In statements commemorating "Transgender Day of Visibility," the White House and Department of Health and Human Services cited research from the Trevor Project to support the use of puberty blockers, hormone therapy, and sex-reassignment procedures in children seeking to change genders. Two of the Trevor Project’s donors, AbbVie and Allergan, make drugs and medical products used in the medical gender transition process. The charitable foundations of...
  • Pfizer and Allergan merger NOT going forward

    04/06/2016 4:07:39 AM PDT · by onona · 15 replies
    Me ^ | today | me
    Pfizer just announced, that based on the Treasury Departments new rules, just created, that they will NOT be moving forward with the merger / inversion.
  • It's Official: Allergan, Pfizer To Combine In Biggest Ever Tax-Inversion, Defy Jack Lew

    11/23/2015 9:02:45 AM PST · by SeekAndFind · 4 replies
    Zero Hedge ^ | 11/23/2015 | Tyler Durden
    As was extensively reported over the weekend, the Pfizer-Allergan tax-inverting, reverse-merger (in which the far The combinsmaller Allergan would end up "buying" Pfizer, courtesy of fungible debt which doesn't care where it ends up as long as there are cash flows) would be announced this morning, and sure enough, moments ago the long-awaited press release finally hit. Here are the details:Pfizer and Allergan to Combine Creates a new global biopharmaceutical leader with best-in-class innovative and established businessesEnhances revenue and earnings growth profile of innovative and established businessesBroadens innovative pipeline with more than 100 combined mid-to-late stage programs in developmentTransaction...
  • FDA OKs 1st Eyelash Drug Latisse -- Promotes Long Lashes, inspired by glaucoma drug

    12/27/2008 1:14:29 PM PST · by Clairity · 12 replies · 2,495+ views
    WebMD ^ | Dec. 26, 2008 | Miranda Hitti
    The FDA has approved Latisse, the first drug to promote eyelash growth, according to Allergan, the company that makes Latisse. Latisse, which will be available by prescription starting in the first quarter of 2009, contains the active ingredient of the glaucoma drug Lumigan, which is also made by Allergan. Eyelash growth is a known side effect of Lumigan. But Lumigan and Latisse are used differently. Lumigan is an eyedrop, and Latisse gets dabbed along the lash line on the upper eyelids to promote longer, thicker, darker lashes. Allergan states that "Latisse users can expect to experience longer, fuller, and darker...